Our results exhibited that METTL3 expression was correlated with tumor size, clinical stage, and distance metastasis (p < 0.05, Supplementary Table 2), and higher METTL3 expression indicated worse overall survival rate (p < 0.05, Fig. 1E). Here, METTL3 is linked to neoplasm.